Acorda Therapeutics, Inc. Profile Avatar - Palmy Investing

Acorda Therapeutics, Inc.

Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis…

Drug Manufacturers - Specialty & Generic
US, Ardsley [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Download
Cash Amount Pay Date
Download
Cash Amount Pay Date
End of ACOR's Analysis
CIK: 1008848 CUSIP: 00484M106 ISIN: US00484M7002 LEI: - UEI: -
Secondary Listings
ACOR has no secondary listings inside our databases.